drugset / Trial / NCT06339788
Pharmacokinetics of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to compare the pharmacokinetics and safety of HD-P023 and coadministration of Teneligliptin and Empagliflozin in healthy adult volunteers
Timeline
- Start
- 2024-05-10
- Primary completion
- 2024-06-12
- Completion
- 2024-06-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Empagliflozin | Small molecule | — | Oral |
| Subject | HD-P023 | Unknown | — | Oral |
| Comparator | Teneligliptin | Small molecule | — | Oral |
Indications
No indication recorded.